Download by
Scanning QR Code
No Stock Yet
Insurance Technology|Looking back at ten years of “transformation”, how to grasp the next ten years?
The end of a reincarnation is also a new beginning.
Waterdrop Inc. Announces Earnings Date Change: First Quarter 2023 Earnings Release Scheduled June 2, 2023
BEIJING, May 30, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact,
Insurance Stocks Moving In Tuesday's Intraday Session
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. GainersFanhua (NASDAQ:FANH) stock rose 23.34% to $8.03 during Tuesday's regular sessi
Waterdrop Inc. to Report First Quarter 2023 Financial Results on June 5, 2023
BEIJING, May 26, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact,
Top 5 Financial Stocks You'll Regret Missing This Quarter
The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up
Recent 7.7% Pullback Isn't Enough to Hurt Long-term Waterdrop (NYSE:WDH) Shareholders, They're Still up 148% Over 1 Year
While Waterdrop Inc. (NYSE:WDH) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 13% in the last quarter. But that doesn'
Waterdrop Inc.'s (NYSE:WDH) Price Is Right But Growth Is Lacking
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 15x, you may consider Waterdrop Inc. (NYSE:WDH) as an attractive investment with its 12.6x P/E ra
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2022
Shuidi Company (WDH.US) and Chia Tai Tianqing Pharmaceutical Group continue to strengthen strategic cooperation to discuss new ideas for win-win development
On April 13, Shen Peng, founder, chairman and CEO of Shuidi Company, led the core person in charge of Shuidi's pharmaceutical innovation business and others to visit the Nanjing Shunxin factory of Chia Da Tianqing Pharmaceutical Group. Xie Chengrun, chairman of Chia Tai Tianqing Pharmaceutical Group, led the executive team to receive a cordial reception.
Express News | CICC gave Shuidi a target price of 3.4 US dollars to maintain the “outperform the industry” rating.
Loading...
No Stock Yet